Natural Course and Therapeutic Effect of Chronic Pancreatitis

Sponsor
Changhai Hospital
Study ID
NCT06925204
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Interventions

  • Observation — OTHER
    Based on the patient's specific clinical condition, the appropriate examination and treatment in accordance with the conventional diagnosis and treatment standards of CP will be performed, including but not limited to: CT, MRI, endoscopic ultrasound (EUS) with or without biopsy, endocrine hormone testing (such as oral glucose tolerance test or mixed meal tolerance testing), pancreatic exocrine function tests (such as fecal elastase-1 test), extracorporeal shock wave lithotripsy (ESWL), endoscopic retrograde cholangiopancreatography (ERCP), and pancreatic enzyme replacement therapy. Patients were followed up regularly.

Study Details

The goal of this observational study is to establish a prospective cohort of chronic pancreatitis (CP) patients to provide evidence-based guidance for clinical practice and comprehensively optimize diagnostic and treatment strategies. The study aims to collect detailed demographic information, clinical data, medical imaging, biological samples, and follow-up information from CP patients.

Key Dates

First listed
Apr 13, 2025
Start date
Apr 13, 2025
Status verified
Apr 2025
Primary completion
Dec 1, 2035
Completion
Dec 31, 2035

Study Design

Enrollment
5,000 participants (estimated)

Arms

  • Arm: chronic pancreatitis
    This group included all enrolled patients with CP.

Primary Outcome Measure

Incidence of complications [ Time Frame: Annually for 10 years post-enrollment (Year 1 through Year 10) ]

Central Contacts

Related Studies